• 10649 Citations
  • 53 h-Index
1979 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 22 Similar Profiles
Hepacivirus Medicine & Life Sciences
Viruses Chemical Compounds
Virus Replication Medicine & Life Sciences
RNA Medicine & Life Sciences
Interferons Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences
Hepatocytes Medicine & Life Sciences
Replicon Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1979 2019

  • 10649 Citations
  • 53 h-Index
  • 238 Article
  • 1 Review article
1 Citation (Scopus)

Acidic polysaccharides isolated from marine algae inhibit the early step of viral infection

Ueno, M., Nogawa, M., Siddiqui, R., Watashi, K., Wakita, T., Kato, N., Ikeda, M., Okimura, T., Isaka, S., Oda, T. & Ariumi, Y., Mar 1 2019, In : International Journal of Biological Macromolecules. 124, p. 282-290 9 p.

Research output: Contribution to journalArticle

Virus Diseases

Ribavirin-induced down-regulation of CCAAT/ enhancer-binding protein α leads to suppression of lipogenesis

Satoh, S., Onomura, D., Ueda, Y., Dansako, H., Honda, M., Kaneko, S. & Kato, N., Jan 15 2019, In : Biochemical Journal. 476, 1, p. 137-149 13 p.

Research output: Contribution to journalArticle

CCAAT-Enhancer-Binding Proteins
1 Citation (Scopus)
GMP synthase (glutamine-hydrolyzing)
Type II DNA Topoisomerase
1 Citation (Scopus)

Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells

Murakami, Y., Sugiyama, K., Ebinuma, H., Nakamoto, N., Ojiro, K., Chu, P. S., Taniki, N., Saito, Y., Teratani, T., Koda, Y., Suzuki, T., Saito, K., Fukasawa, M., Ikeda, M., Kato, N., Kanai, T. & Saito, H., Jun 25 2018, In : BMC Cancer. 18, 1, 680.

Research output: Contribution to journalArticle

NF-E2-Related Factor 2
Liver Neoplasms
Virus Diseases

Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251

Ueda, Y., Gu, W., Dansako, H., Kim, H-S., Yoshizaki, S., Okumura, N., Ishikawa, T., Nishitsuji, H., Kato, F., Hishiki, T., Satoh, S., Ishii, K., Masuda, M., Shimotohno, K., Ikeda, M. & Kato, N., Sep 1 2018, In : Biochemistry and Biophysics Reports. 15, p. 1-6 6 p.

Research output: Contribution to journalArticle

Hepatitis C
Antiviral Agents